The trademark application OMBLASTYS (131 I-omburtamab-ycwd) was filed by Y-mAbs Therapeutics, Inc, a U.S. corporation (the "Applicant"). The application was published for oppositions on October 24, 2022, and it was registered by office on January 31, 2023 without any oppositions.
It was designated 'Basic Application' for International Application 1703770 at the World Intellectual Property Organization (WIPO).
The application was filed in Danish (English was selected as the second language).
Goods And Services
The mark was filed in class 5 with Pharmaceutical preparations and substances for the treatment of cancer and Pharmaceutical preparations and substances for the prevention of cancer..
The mark was filed in class 42 with following description of goods:
Research and development services in the field of antibodies
Research and development services in the field of antibody technology
Laboratory research and analysis in the field of the production of antibodies
Science and technology services, namely Scientific research, testing and analysis Relating to the following sectors: Antibodies and research and design related thereto
Industrial analysis services and Industrial research services, Relating to the following sectors: Antibodies.